Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study

NCT01522742 ·Status: TERMINATED

Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis

NCT00317499 ·Status: COMPLETED ·Phase: PHASE3

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

NCT01543204 ·Status: TERMINATED ·Phase: PHASE4

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

NCT02134210 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

NCT00663052 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

NCT01313221 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

NCT04398732 ·Status: COMPLETED

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

NCT04428411 ·Status: COMPLETED

Safety and Efficacy of Etanercept in Patients With Psoriasis

NCT02258282 ·Status: UNKNOWN ·Phase: NA

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

NCT01891864 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT03982394 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis

NCT03963401 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis

NCT06934226 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

NCT06878404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria

NCT01557283 ·Status: COMPLETED

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

NCT00111449 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis

NCT05364554 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis

NCT00456092 ·Status: COMPLETED ·Phase: PHASE2

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

NCT02207244 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

NCT02584855 ·Status: COMPLETED ·Phase: PHASE3

Study of Etanercept in the Treatment of Psoriasis in Adult Subjects

NCT00121615 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

NCT00809614 ·Status: COMPLETED ·Phase: PHASE2

The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

NCT01971346 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

NCT02346240 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

NCT01172938 ·Status: COMPLETED ·Phase: PHASE3